ASK REDCHAT ANYTHING ABOUT ADIAL PHARMACEUTICALS INC
Adial Pharmaceuticals Inc (NASDAQ: ADIL)
Listen to this Section
$2.27
-0.1510
(
-6.24% )
15.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| AD04DetailsAlcohol use disorderBig Mover™Suspected Mover™Susp. Mover™ |
Phase 3 |
Market Data
|
| Open |
$2.27 |
| Previous Close |
$2.42 |
| Volume |
15.0K |
| Market Cap |
$4.97M |
| Day Range |
$2.25 - $2.42 |
| 52 Week Range |
$1.31 - $18.90 |
| Shares Outstanding |
2.14M |
| Change % |
-6.24% |
| Net Change |
▼ -0.1510 |
| Insider Ownership |
-0.04% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-174,300.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-27 |
Sale |
-42000.00 |
Goodman Tony |
| 2024-03-27 |
Sale |
-12000.00 |
Schuyler Kevin |
| 2024-03-27 |
Sale |
-12000.00 |
Anderson J. Kermit |
| 2024-03-27 |
Sale |
-60000.00 |
Claiborne Cary J |
| 2024-03-27 |
Sale |
-25000.00 |
Truluck Joseph |
| 2024-03-27 |
Sale |
-12000.00 |
Newman James W. Jr. |
| 2024-03-27 |
Sale |
-12000.00 |
Gilliland Robertson H. |
| 2023-10-03 |
Buy |
700.00 |
Schuyler Kevin |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| s-3 |
Registration statements |
17 |
Dec 12, 2025 |
| 8-k |
8K-related |
15 |
Dec 01, 2025 |
| 8-k |
8K-related |
14 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
58 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Sep 16, 2025 |
| s-8 |
Registration statements |
15 |
Sep 09, 2025 |
| 8-k |
8K-related |
14 |
Sep 03, 2025 |
| 8-k |
8K-related |
14 |
Aug 14, 2025 |
| 10-q |
Quarterly Reports |
58 |
Aug 13, 2025 |
| 424b5 |
Other |
2 |
Aug 01, 2025 |